Nursing Elites

1. The nurse is assessing a client with chronic liver disease. Which lab value is most concerning?

• A. Elevated AST and ALT levels
• B. Decreased albumin level
• C. Elevated bilirubin level
• D. Prolonged PT/INR

Correct answer: D

Rationale: In a client with chronic liver disease, a prolonged PT/INR is the most concerning lab value. This finding indicates impaired liver function affecting the synthesis of clotting factors, leading to an increased risk of bleeding. Elevated AST and ALT levels (Choice A) indicate liver cell damage but do not directly correlate with the risk of bleeding. A decreased albumin level (Choice B) is common in liver disease but is not the most concerning in terms of bleeding risk. Elevated bilirubin levels (Choice C) are seen in liver disease but do not directly reflect the risk of bleeding as PT/INR values do.

2. A client with hypothyroidism is being treated with levothyroxine (Synthroid). What is the most important information for the nurse to provide to the client?

• A. Take the medication on an empty stomach
• B. Monitor for signs of hyperthyroidism
• C. Expect to see results within a week
• D. Avoid exposure to sunlight

Correct answer: B

Rationale: The most important information for the nurse to provide to a client with hypothyroidism being treated with levothyroxine is to monitor for signs of hyperthyroidism. Too much levothyroxine can lead to symptoms of hyperthyroidism, indicating an overdose. Choice A is incorrect as levothyroxine is usually taken on an empty stomach to ensure optimal absorption. Choice C is inaccurate as it may take weeks to months to see the full effects of levothyroxine therapy due to the need for dosage adjustments. Choice D is unrelated to levothyroxine therapy and is not a crucial concern for this specific medication.

3. A client is being treated for heart failure. What should the nurse monitor to evaluate treatment effectiveness?

• A. Daily weight
• B. Electrolyte levels
• C. Urine output
• D. All of the above

Correct answer: D

Rationale: Monitoring daily weight, electrolyte levels, and urine output is crucial in evaluating treatment effectiveness for heart failure. Daily weight monitoring helps assess fluid retention or loss, changes in electrolyte levels can indicate imbalances affecting heart function, and urine output monitoring provides insights into kidney function and fluid balance. Therefore, all options are essential components in assessing the patient's fluid status and response to treatment, making 'All of the above' the correct answer. Choices A, B, and C are incorrect individually as they only represent partial aspects of monitoring heart failure treatment effectiveness.

4. A client with a history of atrial fibrillation is prescribed warfarin. Which lab value should the nurse monitor to assess the effectiveness of this medication?

• A. Hemoglobin
• B. White blood cell count
• C. Platelet count
• D. INR

Correct answer: D

Rationale: The correct answer is D, INR (International Normalized Ratio). The INR is used to monitor the effectiveness of warfarin therapy. Warfarin is an anticoagulant medication commonly prescribed for conditions like atrial fibrillation. Monitoring the INR helps healthcare providers ensure that the blood is clotting within a therapeutic range. Hemoglobin (Choice A), white blood cell count (Choice B), and platelet count (Choice C) are not directly related to monitoring the effectiveness of warfarin therapy in this context.

5. The nurse is teaching a client about the administration of a subcutaneous injection. Which site is most appropriate for this type of injection?

• A. Deltoid muscle
• B. Dorsogluteal muscle
• C. Ventrogluteal muscle
• D. Abdomen

Correct answer: D

Rationale: The abdomen is a common site for subcutaneous injections due to its accessibility and ample subcutaneous tissue. Subcutaneous injections are typically given in areas with a layer of fat between the skin and muscle, such as the abdomen, to allow for slow and consistent absorption of the medication. The deltoid muscle is more appropriate for intramuscular injections, not subcutaneous. The dorsogluteal muscle and ventrogluteal muscle are also more suited for intramuscular injections, not subcutaneous.

Similar Questions